NCT00811850 - Comparing Effects of Two Fixed Combinations Ophthalmic Solutions on Ocular Blood Flow | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

December 31, 2008

Primary Completion Date

December 31, 2009

Study Completion Date

December 31, 2009

Conditions

Glaucoma

Interventions

DRUG

fixed combination of brimonidine tartrate 0.2% timolol maleate 0.5% ophthalmic solution

1 drop of study medication taken approximately 12 hours apart, dosed 2 times a day for a total of two weeks

DRUG

fixed combination of dorzolamide hydrochloride timolol maleate ophthalmic solution

1 drop of study medication taken approximately 12 hours apart, dosed 2 times a day for a total of two weeks

Trial Locations (1)

Indianapolis